[ sulge aken ]
Elulookirjeldus (CV) | ||
1. | Eesnimi | Anneli |
2. | Perekonnanimi | Uusküla |
3. | Töökoht | Tervishoiu instituut / Nahahaiguste kliinik Tartu Ülikool |
4. | Ametikoht | Vanemteadur |
5. | Sünniaeg | 11.04.1967 (päev.kuu.aasta) |
6. | Haridus | 1985-1991, TÜ arstiteaduskond ravi eriala 1991-1993, üldinternatuur TÜ kliinikute baasil 1994-1997, residentuur dermatoveneroloogia erialal 1997-2001, doktorikraadiõpe, Tartu ülikool 2001-2003, teadusmagistri õpe epidemioloogia erialal, School of Public Health, State University of New York, USA |
7. | Teenistuskäik | Nahahaiguste Kliinik, Tartu Ülikool, alates 1994 Tervishoiu Instituut, Tartu Ülikool, alates 2001 SA TÜ Nahahaiguste Kliinik, arst õppejõud, alates 2000 |
8. | Teaduskraad | PhD, Tartu Ülikool MS Epi, State University of New York |
9. | Teaduskraadi välja andnud asutus, aasta |
2001 2003 |
10. | Tunnustused | - |
11. | Teadusorganisatsiooniline ja –administratiivne tegevus |
New York Academy of Sciences liige alates 1997, Eesti dermatoveneroloogide selts (juhatuse liige)Sugulisel teel levivate infektsioonide Eesti Ühing (juhatuse liige) Ekspertkomisjonid · Riigi Ravimiameti ekspert (dermatoloogia) · Euroopa Ravimiagentuuri (European Medicines Agency, EMEA), valideeritud ekspert · Tervise Arengu Instituudis Global Fund’i poolt finantseeritud programmi “Scaling up the response to HIV in Estonia” Riigihanke ekspertkomisjoni (Services Procurement Committee for the Global Fund Program in Estonia) liige. · Sotsiaalministeerimi poolt moodustatud töögrupi “Nakkushaiguste registreerimine Eestis” liige (2004) · Sotsiaalministeerimi poolt moodustatud töögrupi “HIV ja AIDSi riikliku strateegia” seire-, monitooringu ja hindamise töörühma liige (2004) |
12. | Juhendamisel kaitstud väitekirjad |
|
13. | Teadustöö põhisuunad | 1) Sugulisel teel levivate infektsioonide ja inimese immuunpuudulikkuse viirusinfektsiooni epidemioloogia Eestis 2) Sugulisel teel levivad infektsioonide ja HIV infektsiooni riskifaktorid 3) Sugulisel teel levivad infektsioonide ja HIV infektsiooni riskifaktorid 4) Suguhaigustesse ja HIV infektsiooni ennetamisele suunatud uuringud |
14. | Jooksvad grandid | 2005 alates Tervisearengu instituut, leping 3.3GF-2/4. Süstiva narkomaaanid Eestis - HIV levimus ja rahvastikuühma suurus (peamine uurnigu läbiviija). 2003 alates Haridus- ja Teadusministeeriumi sihtfinantseering nr 0182128s02. Naha- ja suguhaiguste patogeneesi molekulaarsed mehhanismid ja epidemioloogilised aspektid Eestis (uurija). 2004 alates Haridus- ja Teadusministeeriumi sihtfinantseering nr 0182648s04. Eesti elanike tervise seisundit mõjutavad tegurid: mõõtmismetoddika ja sekkumiste tulemuslikkus. 2004-2005 US Civilian Research & Development Foundation Targeted Research program on HIV/AIDS and Related Infections (CRDF, Proposal Number 13724) (Peamine uuringu läbiviija). 2004-2005 Advanced In-Country Training Grant Fogarty International Training and Research Program at SUNY Downstate Medical Center (peamine uuringu läbiviija). 2004-2007 National Institutes of Health (USA), grant R01 TW06990-01“Homescreening for sexually transmitted infections in Estonia” (peamine uuringu läbiviija). |
15. | Teaduspublikatsioonid |
Naaber P, Uusküla A, Naaber J, Põder A, Hjelm E, Hallen A, Unemo M, Domeika M. Laboratory diagnosis of sexually transmitted infections (STIs) in Estonia in 2001-2002: imperfect with impacts on diagnostic quality and surveillance. Vastuvõetud avaldamiseks ajakirja STD 2005. Rüütel K, Uusküla A. HIV epidemic in Estonia in the third decade of AIDS era. Accepted for publication in Scan J Inf Dis, 2005. Uusküla A, Heimer R, DeHovitz J, Fischer K, McNutt LA. Surveillance of HIV, HBV, and HCV in an Estonian injection drug using population: sensitivity and specificity of testing syringes for public health surveillance. Accepted for publication in JID, 2005. Uuskula A, Nygard-Kibur M, Cowan FM, Mayaud P, French RS, Robinson JN, Brown DW The burden of infection with herpes simplex virus type 1 and type 2: seroprevalence study in Estonia. Scand J Infect Dis 2004;36(10):727-32. Uusküla A, Dehovitz J, McNutt LA. Treatment of the sexually transmitted diseases in Estonia: consistency with the evidence based medicine principles. Sex Transm Dis 2004;31(10):631-5. Uusküla A, Nygard JF, Kibur-Nygard M. Syphilis as a social disease: experience from the post-communist transition period in Estonia. Int J STD AIDS 2004:15(10):662-8. Uusküla A, Raukas E. Atypical genital herpes; report of 5 cases. Scand J Infect Dis 2004;36(1):37-9. Uusküla A, Kalikova N, Zilmer K, Tammai L, DeHovitz J. The role of injecting drug use in the emergence of HIV in Estonia. International Journal of Infectious Diseases 2002;6:23-7. Uusküla A, Kohl PK. Genital mycoplasmas, including Mycoplasma genitalium as sexually transmitted infections. International Journal of STD & AIDS 2002;13:79-85. Wilson TE, Uusküla A, Feldman J, Holman S, DeHovitz J. A case control study of beliefs and behaviors associated with STD occurrence in Estonia. Sexually Transmitted Diseases 2001;28:624-9 |
viimati muudetud: 06.10.2005
Curriculum Vitae (CV) | ||
1. | First Name | Anneli |
2. | Surname | Uusküla |
3. | Institution | Department of Public Health / Department of Dermatology University of Tartu |
4. | Position | Senior researcher |
5. | Date of birth | 11.04.1967 (day.month.year) |
6. | Education | 2001-2003 State University of New York, University at Albany, School of Public Health, MS degree program studies in epidemiology 1997-2001 Tartu University Medical Doctorancy in Dermatovenereology (degree of Doctor of Medical Sciences) 1993-1997 Tartu University Clinic of Dermatovenerology, Medical Residency in Dermatovenerology 1991-1993 Tartu University Medical Internship [1993, Clinician, Department of Obstetrics and Gynecology; 1992, Clinician, Department of Internal Medicine; 1991, Clinician, Department of Surgery] 1985-1991 Tartu University Medical Faculty |
7. | Research and professional experience |
1) Univeristy of Tartu, Dept. of Public Health, since 2001; Dept. of Dermatology, since 1994 2) Foundation of Tartu University Clinics, Clinic of Dermatology, physician-lecturer, since 2000 |
8. | Academic degree | PhD, University of Tartu MS Epi, State University of New York |
9. | Dates and sites of earning the degrees |
2001 2003 |
10. | Honours/awards | - |
11. | Research-administrative experience |
·Member of New York Academy of Sciences ·Society of dermatovenerologists in Estonia (member of board) ·Union against sexually transmitted infections in Estonia (member of board) Expert commitees · Riigi Ravimiameti ekspert (dermatoloogia) · Euroopa Ravimiagentuuri (European Medicines Agency, EMEA), valideeritud ekspert · National Institute of Health, member of the Services Procurement Committee for the Global Fund Program in Estonia · Ministry of Social Affairs, member of the HIV/AIDS national strategy task group |
12. | Supervised dissertations | |
13. | Current research program | Epidemiology, behavioral and health risk Factors, substance abuse patterns, and preventive interventions related to HIV/AIDS and sexually transmitted disease transmission in Estonia |
14. | Current grant funding | 2005 - since, NIHD Estonia, 3.3GF-2/4. Injection drug users in Estonia – Estimating HIV prevalence and the size of the population (Principal investigator). 2003 since, Estonian Ministry of Education, grant nr 0182648s04. 2004 since, Estonian Ministry of Education, grant nr 0182128s02. Molecular epidemiology and pathogenesis on skin diseases (Co-investigator). 2004 - 2005, US CRDF (Civilian Research & Development Foundation), Targeted Research program on HIV/AIDS and Related Infections (CRDF, Proposal Number 13724) (Principal investigator). 2003-2005 Advanced In-Country Training Grant Fogarty International Training and Research Program at SUNY Downstate Medical Center (Principal investigator). 2004-2007 National Institutes of Health (USA), grant R01 TW06990-01“Homescreening for sexually transmitted infections in Estonia” (Principal investigator). |
15. | List of most important publications |
Naaber P, Uusküla A, Naaber J, Põder A, Hjelm E, Hallen A, Unemo M, Domeika M. Laboratory diagnosis of sexually transmitted infections (STIs) in Estonia in 2001-2002: imperfect with impacts on diagnostic quality and surveillance. Vastuvõetud avaldamiseks ajakirja STD 2005. Rüütel K, Uusküla A. HIV epidemic in Estonia in the third decade of AIDS era. Accepted for publication in Scan J Inf Dis, 2005. Uusküla A, Heimer R, DeHovitz J, Fischer K, McNutt LA. Surveillance of HIV, HBV, and HCV in an Estonian injection drug using population: sensitivity and specificity of testing syringes for public health surveillance. Accepted for publication in JID, 2005. Uuskula A, Nygard-Kibur M, Cowan FM, Mayaud P, French RS, Robinson JN, Brown DW The burden of infection with herpes simplex virus type 1 and type 2: seroprevalence study in Estonia. Scand J Infect Dis 2004;36(10):727-32. Uusküla A, Dehovitz J, McNutt LA. Treatment of the sexually transmitted diseases in Estonia: consistency with the evidence based medicine principles. Sex Transm Dis 2004;31(10):631-5. Uusküla A, Nygard JF, Kibur-Nygard M. Syphilis as a social disease: experience from the post-communist transition period in Estonia. Int J STD AIDS 2004:15(10):662-8. Uusküla A, Raukas E. Atypical genital herpes; report of 5 cases. Scand J Infect Dis 2004;36(1):37-9. Uusküla A, Kalikova N, Zilmer K, Tammai L, DeHovitz J. The role of injecting drug use in the emergence of HIV in Estonia. International Journal of Infectious Diseases 2002;6:23-7. Uusküla A, Kohl PK. Genital mycoplasmas, including Mycoplasma genitalium as sexually transmitted infections. International Journal of STD & AIDS 2002;13:79-85. Wilson TE, Uusküla A, Feldman J, Holman S, DeHovitz J. A case control study of beliefs and behaviors associated with STD occurrence in Estonia. Sexually Transmitted Diseases 2001;28:624-9 |
last updated: 06.10.2005
[ sulge aken ]